FGF23 and hypophosphatemia: A rare paraneoplastic disorder. Typically, benign phos-phaturic mesenchymal tumors secrete excessive amounts of fibroblast growth factor-23 (FGF23), resulting in hypophosphatemia, muscle weakness, and an increased risk of fractures